Abstract:A cost-effective, highly selective and sensitive paper-based potentiometric combined sensor for losartan potassium drug (LOS) is fabricated, characterized and used for the drug monitoring. The sensor consists of 2 strips of filter paper (20 × 5 mm each) as platform, each imprinted with 4 mm diameter circular spot of carbon. One carbon spot is covered by a reduced graphene oxide (rGO) for use as a substrate for the recognition sensor and the other without rGO is used for the reference electrode. LOS molecularly imprinted drug polymer (MIP) is applied onto the graphene oxide containing strip to act as a drug recognition sensing material and a solid-state polyvinyl butyral (PVB) is applied onto the second carbon spot to act as a reference electrode. Performance characteristics of the combined sensor are examined with chronopotentiometry (CP) and electrochemical impedance spectroscopy (EIS). Increase effect of rGO on the interfacial double-layer capacitance of the sensing membrane and consequently on the potential stability is confirmed. The developed combined sensor (strip cell) displays a Nernstian slope of -58.2 ± 0.3 mV/decade (R2 = 0.9994) over the linear range 8.5 × 10-7 - 6.9 × 10-2 M with a detection limit of 2.7 ± 0.3 × 10-7 M. The sensor shows remarkable selectivity toward various related compounds especially those commonly used by the COVID-19 patients such as paracetamol, ascorbic acid and dextromethorphan. The assay method is validated and proved to be satisfactory for direct potentiometric determination of LOS-K in some pharmaceutical formulations and in spiked human urine samples. An average recovery of 96.3 ± 0.3-98.7 ± 0.6% of the nominal or spiked concentration and a mean relative standard deviation of ±0.6% are obtained. The use of an indicating and a reference electrodes combined into a single flexible disposable paper platform enables applications to a minimum sample volume due to the close proximity of the responsive membrane and the liquid junction. The efficiency of the proposed sensor in complex urine matrix suggests its application in hospitals for rapid diagnosis of overdose patients and for quality control/quality assurance tests in pharmaceutical industry.

A novel electrochemical sensor based on reduced graphene oxide decorated with gold nanoparticles for voltammetric sensing of amlodipine in human urine

Binder-free and efficient voltammetric sensor based on Zn-Ca2CuO3 nanoparticles for simultaneous determination of amlodipine, acetaminophen, and ascorbic acid in hypertension patients

Highly sensitive quantification of Amlodipine in real samples using graphene oxide-chitosan surface plasmon resonance sensor

A Novel Sensor Based on Electrodeposited Au–Pt Bimetallic Nano-Clusters Decorated on Graphene Oxide (go)–electrochemically Reduced GO for Sensitive Detection of Dopamine and Uric Acid

Disposable Point-of-Care Electrochemical Sensor for Uric Acid Determination in Human Urine Utilizing a Pencil Graphite Electrode Modified with Polydopamine/ Gold Nanoparticles

Utility of Gold/Multiwalled Carbon Nanocomposite for Electrochemical Determination of Omarigliptin in Tablets and Human Plasma

Sensitive detection of dopamine using a platinum microelectrode modified by reduced graphene oxide and gold nanoparticles

Highly sensitive determination of benorilate using silver nanoparticles/polyindole/reduced graphene oxide nanocomposite modified electrode

Electrodeposited NiO/graphene Oxide Nanocomposite: an Enhanced Voltammetric Sensing Platform for Highly Sensitive Detection of Uric Acid, Dopamine and Ascorbic Acid

All-solid-state paper-based potentiometric combined sensor modified with reduced graphene oxide (rGO) and molecularly imprinted polymer for monitoring losartan drug in pharmaceuticals and biological samples

Nanocomposites of poly(l-methionine), carbon nanotube-graphene complexes and Au nanoparticles on screen printed carbon electrodes for electrochemical analyses of dopamine and uric acid in human urine solutions

Molecularly Imprinted Electrochemical Sensor-Based Fe2O3@MWCNTs for Ivabradine Drug Determination in Pharmaceutical Formulation, Serum, and Urine Samples

A Portable Microelectrochemical Sensor Based on Potentiostatic Polarization-Treated and Laser-Induced Graphene for the Simultaneous Determination of Ascorbic Acid, Dopamine, and Uric Acid

Application of Recycled Battery-Graphite Electrode Decorated with Polyglutamic Acid/Au Nanoparticles for Detection of Nalbuphine Drug Abuse

Electrochemical determination of olmesartan medoxomil using hydrothermally prepared nanoparticles composed SnO2-Co3O4 nanocubes in tablet dosage forms

Evaluation of Permselective Polydopamine/rGO Electrodeposited Composite Films for Simultaneous Voltammetric Determination of Acetaminophen and Dopamine

One-Step Electrochemical Fabrication of Reduced Graphene Oxide/Gold Nanoparticles Nanocomposite-Modified Electrode for Simultaneous Detection of Dopamine, Ascorbic Acid, and Uric Acid

Development of An Eco-Friendly and Cost-Effective Electrochemical Sensor for the Simultaneous Detection of Dopamine and Serotonin

Development of enzymeless dopamine sensor with poly(1-naphthylamine)-supported reduced graphene oxide nanocomposite-modified carbon paste electrode

Gold nanoparticles/graphene oxide/β-Cyclodextrin nanocomposite for electrochemical determination of Novafen, a new dosage form, in human serum and pharmaceuticals

Electrochemical Sensor Nanoarchitectonics for Sensitive Detection of Uric Acid in Human Whole Blood Based on Screen-Printed Carbon Electrode Equipped with Vertically-Ordered Mesoporous Silica-Nanochannel Film